Gastrokine 3 Inhibitors
Chemical inhibitors of Gastrokine 3 can function by altering the gastric environment to a state that is non-ideal for the protein's activity. Acetazolamide, a carbonic anhydrase inhibitor, can disrupt pH balance, which is essential for Gastrokine 3's stability and function, leading to its inhibition. Similarly, proton pump inhibitors (PPIs) like omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole can decrease stomach acid production, thereby modifying the acidic conditions necessary for the optimal functioning of Gastrokine 3. These agents change the pH levels in the stomach, which can inhibit the protein's protective role in the gastric mucosa. Histamine H2 receptor antagonists, including ranitidine, famotidine, cimetidine, and nizatidine, act in a similar fashion by reducing gastric acid secretion, which can inhibit Gastrokine 3 by creating a less acidic environment than what the protein typically requires to function effectively.
Other chemical inhibitors can indirectly influence Gastrokine 3 activity by targeting enzymatic pathways and proteases within the gastric mucosa. Pepstatin A, as a specific inhibitor of aspartyl proteases, can inhibit proteases that may be required for the activation or function of Gastrokine 3, although it does not directly target Gastrokine 3 itself. Alpha-1-antitrypsin, which is a serine protease inhibitor, can also indirectly inhibit Gastrokine 3 if the protein's activity is connected to the proteolytic cascade where serine proteases are involved. Inhibition of these serine proteases by alpha-1-antitrypsin can lead to a reduction in the functional activity of Gastrokine 3 due to the protein's reliance on a specific proteolytic environment for its action.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $81.00 $177.00 $434.00 $541.00 $883.00 $1479.00 $2244.00 | 1 | |
Acetazolamide inhibits carbonic anhydrase, which is critical for maintaining pH balance. Gastrokine 3, being a protein involved in gastric mucosal defense, could potentially rely on the precise pH for its stability and function. Inhibition of carbonic anhydrase can disrupt the gastric environment, thereby functionally inhibiting Gastrokine 3. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole is a proton pump inhibitor that reduces stomach acid production. By lowering gastric acidity, it alters the stomach environment where Gastrokine 3 operates, potentially inhibiting its protective function on the gastric epithelium. | ||||||
Ranitidine | 66357-35-5 | sc-203679 | 1 g | $193.00 | ||
Ranitidine is an H2 histamine receptor antagonist that decreases stomach acid production. By changing the gastric environment, it can inhibit Gastrokine 3 by altering the conditions required for its optimal activity. | ||||||
Famotidine | 76824-35-6 | sc-205691 sc-205691A | 500 mg 1 g | $65.00 $111.00 | ||
Famotidine acts as an H2 receptor antagonist, thereby reducing gastric acid secretion. This alteration in the stomach's acidity can functionally inhibit Gastrokine 3 by changing the protein's operational environment. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
Cimetidine, another histamine H2 receptor antagonist, reduces stomach acid secretion. This change in gastric pH can inhibit Gastrokine 3's function by altering the gastric milieu where the protein exerts its effects. | ||||||
Lansoprazole | 103577-45-3 | sc-203101 sc-203101A | 500 mg 1 g | $59.00 $176.00 | 6 | |
Lansoprazole is a proton pump inhibitor that decreases stomach acid secretion. By altering the acidic conditions in the stomach, it can inhibit the function of Gastrokine 3 which is dependent on a specific pH for its activity. | ||||||
Pantoprazole | 102625-70-7 | sc-204830 sc-204830A | 100 mg 500 mg | $89.00 $255.00 | 2 | |
Pantoprazole, a proton pump inhibitor, suppresses gastric acid production. This modification of stomach acidity can functionally inhibit Gastrokine 3 as the protein may require a certain pH for its protective role in the gastric mucosa. | ||||||
Rabeprazole | 117976-89-3 | sc-204872 sc-204872A | 10 mg 25 mg | $349.00 $620.00 | 2 | |
Rabeprazole is a proton pump inhibitor that inhibits gastric acid secretion. By altering the stomach's pH, it can inhibit Gastrokine 3 by impacting the acidic conditions necessary for the protein's function. | ||||||